Logan Paul
Source: @nypost, Twitter, Screenshot

Senate Majority Leader Chuck Schumer (D-NY) is calling on the Food and Drug Administration (FDA) to investigate Logan Paul’s PRIME sports drink brand. Details on this story, below.

U.S. Senator Calling For FDA Investigation

According to the Associated Press, Senator Chuck Schumer is asking the FDA to investigate the sports drink PRIME, co-owned by WWE superstar and YouTube sensation, Logan Paul. The reason for this is the high levels of caffeine in the drink, which is causing concern.

The senator notes that one of the summer’s “hottest status” symbols for kids is a beverage. He states that both buyers and parents need to beware as PRIME is being targeted at youngsters and is a health concern.

Schumer notes the beverage’s high caffeine content, at 200 milligrams per 12 ounces. This is equal to, two cans of Red Bull or six cans of Coke.

Alyx Sealy, PRIME’s spokesperson addressed this in a statement. They note the brand’s top priority is consumer safety, and they welcome talks with the FDA or any other organization regarding suggestions for industry changes that will protect consumers.

Logan Paul
Source: @WrestleOps, Twitter, Screenshot


Wrestling fans have seen PRIME advertised during WWE programming quite a bit. During Logan Paul’s WM 39 entrance, he walked that aisle with a life-sized caricature bottle of the bevy by his side. Of course, as the match progressed, it was revealed that KSI, Paul’s business partner, and fellow influencer was behind the costume.

PRIME has had issues with advertising and is marketed as a zero-sugar drink. However, cross-promotions with the WWE have likely helped boost sales.

Logan Paul
Source: @BRWrestling, Twitter, Screenshot

Logan first entered the WWE in 2021, when he sat ringside for the Sami Zayn versus Kevin Owen’s WrestleMania 37 match. The following year he dove into the action as Miz’s partner at WM 38.

Since, he’s signed a contract with the company, wrestling on a part-time basis. WNZ will keep fans posted on this ongoing FDA investigation.